医学
疾病
移植
粪便细菌疗法
粪便
内科学
免疫学
胃肠病学
帕金森病
退行性疾病
中枢神经系统疾病
肠道菌群
梅德林
抗生素
作者
Maria Antônia Oliveira Machado Pereira,Gabriel Caruso Novaes Tudella,Augusto Utida Klostermann,Victor Arthur Ohannesian,Ocílio Ribeiro Gonçalves,Rebeca Oliveira da Silva,João Vítor Andrade Fernandes,Adil Ahmed,Ana Beatriz Alencar,Sandra Tuany Alves de Morais,Kelson James Almeida
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2026-06-16
卷期号:107 (1): e218175-e218175
被引量:1
标识
DOI:10.1212/wnl.0000000000218175
摘要
BACKGROUND AND OBJECTIVES: Parkinson disease (PD) is a progressive neurodegenerative disorder increasingly linked to gut microbiota dysbiosis, which may influence disease mechanisms and symptom expression. Fecal microbiota transplantation (FMT) targets the gut-brain axis, but clinical evidence remains inconsistent. This study aimed to evaluate the efficacy and safety of FMT in PD. METHODS: We conducted a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, with protocol registration in International Prospective Register of Systematic Reviews (CRD420251142846). MEDLINE, Embase, and the Cochrane Library were searched from inception through September 2025. Randomized controlled trials (RCTs) and observational studies enrolling adults with mild-to-moderate PD who received FMT through any administration route were eligible. The primary outcome was motor function assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) part III. Secondary outcomes included UPDRS part II, quality of life (Parkinson's Disease Questionnaire-39 [PDQ-39]), constipation severity (Wexner score), and adverse events. Random-effects models pooled effect estimates with 95% CIs, and exploratory meta-regression assessed follow-up duration, publication year, and sample size. RESULTS: = 0.043). FMT was generally well tolerated; however, gastrointestinal adverse events were more frequent in the FMT group (risk ratio 3.12, 95% CI 1.14-8.53), predominantly mild to moderate. DISCUSSION: FMT may provide short-term improvements in motor and gastrointestinal symptoms in PD, but effects appear transient. Small sample sizes, heterogeneity, and limited follow-up restrict conclusions, underscoring the need for larger randomized trials. Pooled estimates reflected evidence from observational studies and should be interpreted cautiously.
科研通智能强力驱动
Strongly Powered by AbleSci AI